Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy

Clinical trial NCT02423707 · COMPLETED

Trial details

NCT number: NCT02423707
Sponsor: Karolinska Institutet
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2010-08-01
Primary completion: 2015-11-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.